Warning: The NCBI web site requires JavaScript to function. more...
Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategies.
Häupl T, Krenn V, Stuhlmüller B, Radbruch A, Burmester GR.
Arthritis Res Ther. 2004;6(4):140-6. Epub 2004 Jun 4. Review.
Related citations
Where are we in genomics?
Hocquette JF.
J Physiol Pharmacol. 2005 Jun;56 Suppl 3:37-70. Review.
Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
Aardema MJ, MacGregor JT.
Mutat Res. 2002 Jan 29;499(1):13-25. Review.
Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA.
Oncologist. 1996;1(3):II-III.
Molecular diagnostics.
Braziel RM, Shipp MA, Feldman AL, Espina V, Winters M, Jaffe ES, Petricoin EF 3rd, Liotta LA.
Hematology Am Soc Hematol Educ Program. 2003:279-93. Review.
Classification of sarcomas using bioinformatics and molecular profiling.
Dang TA, Man TK.
Curr Pharm Biotechnol. 2007 Apr;8(2):83-91. Review.
Functional genomics and proteomics--the role of nuclear medicine.
Haberkorn U, Altmann A, Eisenhut M.
Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):115-32. Epub 2001 Nov 14. Review.
Technology evaluation: SAGE, Genzyme molecular oncology.
Bartlett J.
Curr Opin Mol Ther. 2001 Feb;3(1):85-96. Review.
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P.
Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S45-56. Epub 2003 Jun 18. Review.
Genomic medicine and the future of health care.
Sander C.
Science. 2000 Mar 17;287(5460):1977-8.
The 7 TM G-protein-coupled receptor target family.
Jacoby E, Bouhelal R, Gerspacher M, Seuwen K.
ChemMedChem. 2006 Aug;1(8):761-82. Review.
Genomic and proteomic technologies for individualisation and improvement of cancer treatment.
Wulfkuhle J, Espina V, Liotta L, Petricoin E.
Eur J Cancer. 2004 Nov;40(17):2623-32. Review.
Molecular profiling approaches for identifying novel biomarkers.
Bailey WJ, Ulrich R.
Expert Opin Drug Saf. 2004 Mar;3(2):137-51. Review.
Predictive pathology of cytostatic drug resistance and new anti-cancer targets.
Dietel M.
Recent Results Cancer Res. 2007;176:25-32. Review.
[New aspects of molecular biology diagnosis. Array technology and expression profile for characterization of rheumatic diseases].
Häupl T, Burmester GR, Stuhlmüller B.
Z Rheumatol. 2002 Aug;61(4):396-404. Review. German.
Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH, Quo CF, Wang MD.
Prog Brain Res. 2006;158:83-108. Review.
New cancer biomarkers deriving from NCI early detection research.
Verma M, Srivastava S.
Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. Review.
[Diagnosis and therapy monitoring applying methods of molecular medicine].
Kekow J, Drynda S.
Z Rheumatol. 2002;61 Suppl 2:II/6-9. Review. German.
Molecular biology and reproduction.
McDonough PG.
Keio J Med. 1999 Mar;48(1):12-21. Review.
Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease?
Marziliano N, Grasso M, Pilotto A, Porcu E, Tagliani M, Disabella E, Diegoli M, Pasotti M, Favalli V, Serio A, Gambarin F, Tavazzi L, Klersy C, Arbustini E.
J Cardiovasc Med (Hagerstown). 2009 May;10(5):433-42.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on